{"version":1,"type":"rich","provider_name":"Libsyn","provider_url":"https:\/\/www.libsyn.com","height":90,"width":600,"title":"The State of Health Tech Venture Capital, with Tamar Rudnick","description":"Tamar Rudnick is a healthcare executive who has spent 10+ years in leadership roles across early-stage, public company, and PE-backed businesses. She is currently an Operating Partner at Define Ventures, one of the largest early-stage digital health VCs with ~$800M under management and $22B in exited value. At Define Ventures, Tamar leads strategic growth initiatives. Based in Silicon Valley, Define invests in early-stage companies from Seed stage to Series B, and has backed and built some of the category-leading companies such as Livongo, HIMS, and Evolent. Define differentiates itself by providing unparalleled expertise in go-to-market and commercialization. Tamar leads this work\u2014developing relationships with a coalition of industry-leading Payers, Health Systems, and Life Sciences companies. To date, Define has delivered customer contracts for over 50% of their portfolio companies. Prior to Define Ventures, Tamar was the SVP of Growth at apree health, where she was responsible for leading Sales, Enablement, Marketing, and Customer teams across Employer and Health Plan segments. apree health is a leader in tech-enabled primary care delivery for commercial organizations, including Fortune 500 Employers and National Health Plans with Elevance as a key strategic partner. apree health was formed as a combination of Castlight Health and Vera Whole Health. At apree, Tamar led the commercial team, delivering 30% revenue growth for the combined business while integrating two commercial organizations and developing the combined go-to- market strategy. What you\u2019ll learn about in this episode:  The current state of the health tech venture capital space Trends within the health tech space, including  Regulatory trends and shifts that are both positively and negatively impacting the startup space Generative AI\u2019s ability and potential to drive efficiency and reduce operational costs GLP-1s and how they are driving the consumerization of healthcare   Where AI is having an impact in the healthcare space and how to discern the signal from the noise The key findings from Define Ventures' recent study of the health tech space, including a deep dive into funding trends and exits The importance of go-to-market and brand strategies in the startup environment  Additional resources:&amp;nbsp;  Tamar Rudnick on LinkedIn Define Ventures website  Define Ventures Health Tech Report Josh Dougherty on LinkedIn Josh Dougherty\u2019s speaking site A Brave New\u2019s website  ","author_name":"A Brave New Podcast","author_url":"http:\/\/abravenew.libsyn.com\/website","html":"<iframe title=\"Libsyn Player\" style=\"border: none\" src=\"\/\/html5-player.libsyn.com\/embed\/episode\/id\/36645205\/height\/90\/theme\/custom\/thumbnail\/yes\/direction\/forward\/render-playlist\/no\/custom-color\/88AA3C\/\" height=\"90\" width=\"600\" scrolling=\"no\"  allowfullscreen webkitallowfullscreen mozallowfullscreen oallowfullscreen msallowfullscreen><\/iframe>","thumbnail_url":"https:\/\/assets.libsyn.com\/secure\/item\/36645205"}